Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 468

The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.

Metabolic network failures in Alzheimer's disease: A biochemical road map

Open access
Toledo, Jon B., Arnold, Matthias, Kastenmüller, Gabi, Chang, Rui, Baillie, Rebecca A., Han, Xianlin, Thambisetty, Madhav, Tenenbaum, Jessica D., Suhre, Karsten, Thompson, J. Will, John‐Williams, Lisa St., MahmoudianDehkordi, Siamak, Rotroff, Daniel M., Jack, John R., Motsinger‐Reif, Alison, Risacher, Shannon L., Blach, Colette, Lucas, Joseph E., Massaro, Tyler, Louie, Gregory, Zhu, Hongjie, Dallmann, Guido, Klavins, Kristaps, Koal, Therese, Kim, Sungeun, Nho, Kwangsik, Shen, Li, Casanova, Ramon, Varma, Sudhir, Legido‐Quigley, Cristina, Moseley, M. Arthur, Zhu, Kuixi, Henrion, Marc Y.R., van der Lee, Sven J., Harms, Amy C., Demirkan, Ayse, Hankemeier, Thomas, van Duijn, Cornelia M., Trojanowski, John Q., Shaw, Leslie M., Saykin, Andrew J., Weiner, Michael W., Doraiswamy, P. Murali, Kaddurah‐Daouk, Rima·2017·Alzheimer's & Dementia

Abstract

Introduction: The Alzheimer's Disease Research Summits of 2012 and 2015 incorporated experts from academia, industry, and nonprofit organizations to develop new research directions to transform our understanding of Alzheimer's disease (AD) and propel the development of critically needed therapies. In response to their recommendations, big data at multiple levels are being generated and integrated to study network failures in disease. We used metabolomics as a global biochemical approach to identify peripheral metabolic changes in AD patients and correlate them to cerebrospinal fluid pathology markers, imaging features, and cognitive performance. Methods: Fasting serum samples from the Alzheimer's Disease Neuroimaging Initiative (199 control, 356 mild cognitive impairment, and 175 AD participants) were analyzed using the AbsoluteIDQ‐p180 kit. Performance was validated in blinded replicates, and values were medication adjusted. Results: Multivariable‐adjusted analyses showed that sphingomyelins and ether‐containing phosphatidylcholines were altered in preclinical biomarker‐defined AD stages, whereas acylcarnitines and several amines, including the branched‐chain amino acid valine and α‐aminoadipic acid, changed in symptomatic stages. Several of the analytes showed consistent associations in the Rotterdam, Erasmus Rucphen Family, and Indiana Memory and Aging Studies. Partial correlation networks constructed for Aβ 1–42, tau, imaging, and cognitive changes provided initial biochemical insights for disease‐related processes. Coexpression networks interconnected key metabolic effectors of disease. Discussion: Metabolomics identified key disease‐related metabolic changes and disease‐progression‐related changes. Defining metabolic changes during AD disease trajectory and its relationship to clinical phenotypes provides a powerful roadmap for drug and biomarker discovery.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2017.01.020

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 83 references

Cited by

See all 468

Metadata

Authors
Toledo, J. B., Arnold, M., Kastenmüller, G., Chang, R., Baillie, R. A., Han, X., Thambisetty, M., Tenenbaum, J. D., Suhre, K., Thompson, J. W., John‐Williams, L. S., MahmoudianDehkordi, S., Rotroff, D. M., Jack, J. R., Motsinger‐Reif, A., Risacher, S. L., Blach, C., Lucas, J. E., Massaro, T., Louie, G., Zhu, H., Dallmann, G., Klavins, K., Koal, T., Kim, S., Nho, K., Shen, L., Casanova, R., Varma, S., Legido‐Quigley, C., Moseley, M. A., Zhu, K., Henrion, M. Y. R., van der Lee, S. J., Harms, A. C., Demirkan, A., Hankemeier, T., van Duijn, C. M., Trojanowski, J. Q., Shaw, L. M., Saykin, A. J., Weiner, M. W., Doraiswamy, P. M., & Kaddurah‐Daouk, R.
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2017-03-21
Volume
13
Issue
9
Pages
965-984
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W2603228471
Cited by
468
References
83
FWCI
28.50
Type
journal article
Language
en
Open access
green
Funders
  • National Institute on Aging (R01AG046171, RF1AG051550, 3U01AG024904‐09S4, P50 NS053488, R01 AG19771, P30 AG10133, P30 AG10124, K01 AG049050)
  • U.S. National Library of Medicine (R01 LM011360, R00 LM011384)
  • National Institute of Biomedical Imaging and Bioengineering (R01 EB022574)
  • Alzheimer's Association
  • National Institutes of Health (U01 AG024904)
  • U.S. Department of Defense (W81XWH‐12‐2‐0012)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabolic network failures in Alzheimer's disease: A biochemical road map. https://app.cochat.ai/papers/10.1016/j.jalz.2017.01.020
The paper
Toledo, J. B., Arnold, M., Kastenmüller, G., Chang, R., Baillie, R. A., Han, X., Thambisetty, M., Tenenbaum, J. D., Suhre, K., Thompson, J. W., John‐Williams, L. S., MahmoudianDehkordi, S., Rotroff, D. M., Jack, J. R., Motsinger‐Reif, A., Risacher, S. L., Blach, C., Lucas, J. E., Massaro, T., . . . Kaddurah‐Daouk, R. (2017). Metabolic network failures in Alzheimer's disease: A biochemical road map. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2017.01.020

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.